3,5-Dibromo-1-cyclopropyl-pyrazin-2-one, 98%, 100mg

5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2-AMINE, 95.0%, 250mg

5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid, 96%, 250mg

(S)-4-Bromo-1-(pyrrolidin-3-yl)-1H-pyrazole hydrochloride, 1g

4-Fluoro-2-isopropoxyaniline hydrochloride, 95.0%, 10g

5,5-DIMETHYL-2-PHENYL-OXAZOLIDIN-4-ONE, 95.0%, 1g

2-Bromo-1-fluoro-4-methoxybenzene, 95.0%, 5g

3-Chloropyrido[3,4-b]pyrazine, 98%, 25mg

2-Methylindole-3-acetic acid, 97.0%, 1g

4-allyl-5-[(4-methoxyphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

3-(4-Bromo-phenyl)-prop-2-yn-1-ol, 250mg

n-(Tert-butoxycarbonyl)-N-butylglycine, 98%, 250mg

3'-Azido-2'3'-ddCTP, ≥95%, 100 µl, plastic packaging.